Talk to your doctor if you need a new prescription. Make sure you refill your insulin on time. It is important to use your insulin as prescribed by your doctor. Once your deductible has been met, it may be less expensive to go through your insurance company.Buying your insulin through this program may not count toward your deductible.Please consider your current prescription insurance coverage each month before using this program.The full Prescribing Information and Important Safety Information about EGRIFTA SV ® are available here. In addition, the production is not affected for EGRIFTA SV ® at this stage by the COVID-19 situation. Rest assured that we presently have enough inventory, here in the U.S., for all currently prescribed and new EGRIFTA SV ® patients. We provide support in the form of injection training, insurance coverage analysis and co-pay assistance. Should you have any questions related to EGRIFTA SV ®, we are here to help through THERA patient support ® ( 1-83, Mon-Fri 8:30AM-8:00PM ET). We are here to assist you and your team in any way that we can.įor patients in need of EGRIFTA SV ® every step has been taken to assure new patients will be taken care of.įor current EGRIFTA SV ® patients, we are fully prepared to support them in light of the COVID-19 situation. is to ensure the health of persons with HIV and the continuity of care for any patient in need of EGRIFTA SV ® during the COVID-19 period. Our primary objective at Theratechnologies Inc. Important Information Regarding EGRIFTA SV ® (tesamorelin for injection) and COVID-19 Pandemic. For more information about EGRIFTA SV ® contact THERA patient support ® toll-free at 1-833-23THERA (1-83). For additional information about EGRIFTA SV ®, see the full Prescribing Information, Patient Information, Patient Instructions for Use, and talk to your doctor. This information is not intended to replace discussions with your doctor. You may report side effects to FDA at 1-80 or to THERA patient support ® toll-free at 1-833-23THERA (1-83). Call your doctor for medical advice about side effects. For more information, ask your healthcare provider or pharmacist. These are not all of the possible side effects of EGRIFTA SV ®. The most common side effects of EGRIFTA SV ® include: Increased risk of death in people who have critical illness because of heart or stomach surgery, trauma or serious breathing (respiratory) problems has happened when taking certain growth hormones. Injection site reactions are a common side effect of EGRIFTA SV ®, but may sometimes be serious. Increase in blood sugar (glucose) or diabetes. Call your healthcare provider if you have swelling, an increase in joint pain, or pain or numbness in your hands or wrist. If you have any of these symptoms, stop using EGRIFTA SV ® and get emergency medical help right away. Serious allergic reaction such as rash or hives anywhere over the body or on the skin, swelling of the face or throat, shortness of breath or trouble breathing, fast heartbeat, feeling of faintness or fainting, itching and reddening or flushing of the skin. Your healthcare provider will do blood tests to check your IGF-1 levels while you are taking EGRIFTA SV ®. Increased levels of your insulin-like growth factor-1 (IGF-1). Stop using EGRIFTA SV ® if any cancer symptoms come back. Increased risk of new cancer in HIV positive patients or your cancer coming back (reactivation). Have problems with blood sugar or diabetes.Īre taking any other prescription and non-prescription medicines, vitamins, and herbal supplements.ĮGRIFTA SV ® may cause serious side effects including: If you become pregnant, stop using EGRIFTA SV ® and talk with your healthcare provider.īefore using EGRIFTA SV ®, tell your healthcare provider if you: Have a pituitary gland tumor, surgery, or other problems related to your pituitary gland, or have had radiation treatment to your head or head injury.Īre allergic to tesamorelin or any of the ingredients in EGRIFTA SV ®.Īre pregnant or become pregnant. It is not known if EGRIFTA SV ® is safe and effective in children, do not use in children. It is not known whether taking EGRIFTA SV ® helps improve how well you take your antiretroviral medications. The long-term safety of EGRIFTA SV ® on the heart and blood vessels (cardiovascular) is not known. EGRIFTA SV ® is a growth hormone-releasing factor (GHRF) analog.ĮGRIFTA SV ® is not for weight loss management. What is EGRIFTA SV ® (tesamorelin for injection)?ĮGRIFTA SV ® is an injectable prescription medicine used to reduce excess abdominal fat in adult patients living with HIV and lipodystrophy.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |